FibroBiologics, Inc. (NASDAQ:FBLG)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$18.1M
- Net margin
- —
Little or no net debt.
- Total debt
- $1.5M
- Cash
- $3.5M
- Debt / equity
- 0.32
Comfortably covers what is due within a year.
- Current assets
- $5.8M
- Current liabilities
- $2.2M
- Current ratio
- 2.64
Consumes cash and must keep raising it.
- Operating cash flow
- -$14.8M
- Free cash flow
- -$14.8M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 3.8M
- Share growth (1y)
- 95.3%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
FBLG Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 234.00 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -234.00 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.38 M | 2.12 M | 1.79 M | 2.25 M | 2.45 M | 2.75 M |
| R&D Expense | 1.66 M | 2.95 M | 797.00 K | 2.79 M | 2.04 M | 1.78 M |
| Operating Expenses | 4.03 M | 5.07 M | 2.36 M | 5.04 M | 4.49 M | 4.53 M |
| Operating Income | -4.03 M | -5.07 M | -2.59 M | -5.04 M | -4.49 M | -4.53 M |
| Pretax Income | -4.12 M | -5.00 M | -3.24 M | -5.78 M | -4.66 M | -4.97 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -4.12 M | -5.00 M | -3.24 M | -5.78 M | -4.66 M | -4.97 M |
| EPS (Basic) | -1.09 | -1.33 | -0.98 | -2.60 | -2.40 | -2.80 |
| EPS (Diluted) | -1.09 | -1.33 | -0.98 | -2.60 | -2.40 | -2.80 |
| Shares Outstanding | 3.77 M | 3.77 M | 3.33 M | 2.15 M | 1.93 M | 1.83 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.